Glaucoma News

Identifying and aggressively treating factors leading to fast progression of glaucoma may decrease the visual disability of the disease, according to findings published in the American Journal of Ophthalmology.

Changes in IOP resulting from posture shifts were comparable among various forms of glaucoma, according to findings published in Optometry Vision and Science.

The presence of glaucoma was significantly associated with increased nighttime BP, according to a study published in JAMA Ophthalmology.

High serum cholesterol levels are associated with increased risk for primary open-angle glaucoma, while 5 or more years of statin use decrease the risk, a recent study suggests.

A 71-year-old Native American female presented with a chief complaint of constant blurred vision at distance and near in the right eye, which began 2 weeks ago.

Glaucoma is traditionally characterized by progressive loss of the retinal ganglion cell layer, leading to visual field defects, advancing to central islands and, finally, total blindness. However, that may change in the future.

The Ahmed ClearPath glaucoma drainage device has been commercially launched in the United States, New World Medical announced in a press release.

Once-daily netarsudil was noninferior to twice-daily timolol for IOP-lowering efficacy in patients with open-angle glaucoma or ocular hypertension, according to the phase 3 ROCKET-4 study.

Graybug Vision has closed $80 million in Series C financing, which will be used to advance its pan-VEGF inhibitor GB-102 into phase 2 studies and its potential glaucoma treatment GB-401 into the clinic, according to a press release.

The FDA has issued multiple approvals and denials of drugs, formulations and devices over the past month.